Komori
Tri Chemical Laboratories (4369) · FactRevenue and Profit Growth for the Interim Period

Quarterly Revenue and Profit Growth

First written in FY2017-Q1. 17 of 41 entries say "Restated". Latest entry: FY2027-H1.

41entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY2027-H12016: 320162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 52026
Same theme, other companies
Trends in performance and profitability, including sales and profit growth and changesA theme 616 companies write about · 47 as a headwind · 761 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 126 companies compared. The sentences above are computed from all 126.Comparing 200 of the theme's 894 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Revenue and Profit Growth for the Interim PeriodAnnual report

    「As a result, revenue was ¥14,705.866 million, up 18.8% year on year, and operating income was ¥3,838.236 million, up 20.8%. Ordinary income was ¥4,526.223 million, up 19.1%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while interim net income attributable to owners of the parent was ¥3,373.555 million, up 21.5%.」

    For the interim consolidated accounting period, revenue, operating income, ordinary income and interim net income attributable to owners of the parent all increased year on year.
  3. FY2026Higher full-year revenue and profitAnnual report

    「As a result, revenue was ¥23,883.175 million, up 26.3% year on year, and operating income was ¥5,902.226 million, up 12.3%. Ordinary income was ¥7,090.219 million, up 7.7%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥5,515.240 million, up 11.1%.」

    Revenue, operating income, ordinary income and net income attributable to owners of the parent all increased year on year.
  4. FY2026-H1Revenue and Profit Growth for the Interim PeriodAnnual report

    「As a result, revenue was ¥12,375.159 million, up 55.2% year on year, and operating income was ¥3,177.676 million, up 63.9%. Ordinary income was ¥3,800.226 million, up 41.8%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while interim net income attributable to owners of the parent was ¥2,776.911 million, up 36.7%.」

    For the interim consolidated accounting period, revenue, operating income, ordinary income and interim net income attributable to owners of the parent all increased year on year.
  5. FY2025Return to full-year revenue and profit growthAnnual report

    「As a result, revenue was ¥18,905.888 million, up 68.1% year on year, and operating income was ¥5,256.445 million, up 169.8%. Ordinary income was ¥6,583.264 million, up 100.9%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥4,961.998 million, up 100.8%.」

    Revenue, operating income, ordinary income and net income attributable to owners of the parent all increased, reversing the previous year's full-year declines in revenue and profit.
  6. FY2025-H1Revenue and Profit Growth for the Interim PeriodAnnual report

    「As a result, revenue was ¥7,974.506 million, up 41.8% year on year, and operating income was ¥1,939.360 million, up 76.2%. Ordinary income was ¥2,680.484 million, up 40.6%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while interim net income attributable to owners of the parent was ¥2,031.294 million, up 39.8%.」

    For the interim consolidated accounting period, revenue, operating income, ordinary income and interim net income attributable to owners of the parent all increased year on year.
  7. FY2025-Q1First-quarter revenue growth and profit declineAnnual report

    「As a result, revenue was ¥3,274.573 million, up 1.4% year on year, and operating income was ¥664.972 million, down 24.0%. Ordinary income was ¥1,068.300 million, down 17.7%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥812.269 million, down 18.2%.」

    First-quarter revenue increased 1.4% year on year, while operating income, ordinary income and net income attributable to owners of the parent all declined.
  8. FY2024Full-year revenue and profit declineAnnual report

    「As a result, revenue was ¥11,246.293 million, down 18.5% year on year, and operating income was ¥1,947.989 million, down 44.4%. Ordinary income was ¥3,276.706 million, down 47.0%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥2,470.625 million, down 48.9%.」

    Revenue, operating income, ordinary income and net income attributable to owners of the parent all fell below the previous year, resulting in lower revenue and lower profit for the full year.
  9. FY2024-Q3Third-quarter revenue and profit declineAnnual report

    「As a result, revenue was ¥8,215.001 million, down 19.0% year on year, and operating income was ¥1,366.038 million, down 51.6%. Ordinary income was ¥2,439.365 million, down 56.5%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥1,848.324 million, down 57.7%.」

    For the cumulative third quarter, revenue, operating income, ordinary income and net income attributable to owners of the parent all declined year on year.
  10. FY2024-Q2Second-quarter revenue and profit declineAnnual report

    「As a result, revenue was ¥5,622.408 million, down 14.1% year on year, and operating income was ¥1,100.924 million, down 42.4%. Ordinary income was ¥1,906.574 million, down 45.7%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥1,453.262 million, down 46.2%.」

    For the cumulative second quarter, revenue, operating income, ordinary income and net income attributable to owners of the parent all declined year on year.
  11. FY2024-Q1Revenue growth and profit declineAnnual report

    「Revenue was ¥3,228.645 million, up 3.5% year on year, while operating income was ¥874.722 million, down 11.4%. Ordinary income was ¥1,298.525 million, down 24.4%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥992.456 million, down 23.3%.」

    Revenue increased year on year, while operating profit, ordinary profit and quarterly net profit attributable to owners of the parent declined.
  12. FY2023Full-year revenue and profit growthAnnual report

    「Revenue was ¥13,803.392 million, up 19.3% year on year, and operating income was ¥3,504.624 million, up 17.8%. Ordinary income was ¥6,186.508 million, up 16.8%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥4,832.417 million, up 18.0%.」

    For the full year, revenue, operating income, ordinary income and net income attributable to owners of the parent all increased year on year.
  13. FY2023-Q3Third-quarter revenue and profit growthAnnual report

    「As a result, revenue was ¥10,139.113 million, up 18.9% year on year, and operating income was ¥2,821.141 million, up 20.0%. Ordinary income was ¥5,613.802 million, up 37.8%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥4,374.728 million, up 38.5%.」

    For the cumulative third quarter, revenue, operating income, ordinary income and net income attributable to owners of the parent all increased year on year.
  14. FY2023-Q2Second-quarter revenue and profit growthAnnual report

    「As a result, revenue was ¥6,548.819 million, up 22.0% year on year, and operating income was ¥1,911.473 million, up 31.1%. Ordinary income was ¥3,508.248 million, up 43.3%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥2,703.669 million, up 43.7%.」

    For the cumulative second quarter, revenue, operating income, ordinary income and net income attributable to owners of the parent all increased year on year.
  15. FY2023-Q1First-quarter revenue and profit growthAnnual report

    「As a result, revenue was ¥3,119.911 million, up 20.2% year on year, and operating income was ¥986.750 million, up 36.5%. Ordinary income was ¥1,718.285 million, up 39.2%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥1,293.488 million, up 37.0%.」

    For the cumulative first quarter, the company disclosed year-on-year increases in revenue, operating income, ordinary income and net income attributable to owners of the parent.
  16. FY2022Full-year revenue and profit growthAnnual report

    「As a result, revenue was ¥11,574.455 million, up 18.1% year on year, and operating income was ¥2,976.074 million, up 10.6%. Ordinary income was ¥5,294.861 million, up 22.5%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥4,095.086 million, up 21.3%.」

    Full-year revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the previous year.
  17. FY2022-Q3Third-quarter revenue and profit growthAnnual report

    「As a result, revenue was ¥8,527.370 million, up 16.2% year on year, and operating income was ¥2,350.907 million, up 6.7%. Ordinary income was ¥4,074.844 million, up 19.0%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥3,159.037 million, up 18.1%.」

    For the cumulative third quarter, all of revenue, operating income, ordinary income and net income attributable to owners of the parent increased year on year. Operating income also returned to growth from the higher-revenue, lower-operating-income situation seen in the previous quarter.
  18. FY2022-Q2Higher revenue alongside lower operating incomeAnnual report

    「As a result, revenue was ¥5,367.109 million, up 11.5% year on year, and operating income was ¥1,457.735 million, down 5.8%. Ordinary income was ¥2,448.794 million, up 6.6%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥1,881.615 million, up 4.7%.」

    Revenue, ordinary income and net income attributable to owners of the parent increased year on year, while operating income declined 5.8%, resulting in higher revenue alongside lower operating income.
  19. FY2022-Q1RestatedAnnual report

    「As a result, revenue was ¥2,594.548 million, up 13.4% year on year, and operating income was ¥723.149 million, up 1.4%. Ordinary income was ¥1,234.792 million, up 12.3%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥944.122 million, up 9.2%.」

    For the cumulative first quarter, the company disclosed that revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the same period of the previous year.
  20. FY2021RestatedAnnual report

    「Revenue was ¥9,801.982 million, up 18.6% year on year, and operating income was ¥2,691.380 million, up 15.7%. Ordinary income was ¥4,323.329 million, up 15.5%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥3,377.281 million, up 14.9%.」

    Full-year revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the previous year.
  21. FY2021-Q3RestatedAnnual report

    「As a result, revenue was ¥7,339.914 million, up 20.0% year on year, and operating income was ¥2,203.044 million, up 31.7%. Ordinary income was ¥3,424.076 million, up 29.1%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥2,674.085 million, up 29.6%.」

    For the cumulative third quarter, the company disclosed that revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the same period of the previous year.
  22. FY2021-Q2RestatedAnnual report

    「As a result, revenue was ¥4,812.155 million, up 15.9% year on year, and operating income was ¥1,547.176 million, up 34.1%. Ordinary income was ¥2,296.682 million, up 29.2%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥1,796.421 million, up 30.3%.」

    For the cumulative second quarter, the company disclosed that revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the same period of the previous year.
  23. FY2021-Q1RestatedAnnual report

    「Revenue was ¥2,287.163 million, up 10.3% year on year, and operating income was ¥713.396 million, up 21.8%. Ordinary income was ¥1,099.958 million, up 20.8%, reflecting the recognition of equity-method investment gains related to the Korean affiliate SK Tri Chem Co., Ltd. and other factors, while net income attributable to owners of the parent was ¥864.386 million, up 21.9%.」

    For the cumulative first quarter, the company disclosed that revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the same period of the previous year.
  24. FY2020RestatedAnnual report

    「Revenue was ¥8,267.457 million, up 6.1% year on year, operating income was ¥2,326.925 million, up 8.1%, ordinary income was ¥3,744.290 million, up 27.7%, and net income attributable to owners of the parent was ¥2,939.792 million, up 29.7%.」

    Full-year revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the previous year.
  25. FY2020-Q3RestatedAnnual report

    「As a result, revenue was ¥6,115.973 million, up 5.8% year on year, and operating income was ¥1,673.111 million, up 5.4%. Ordinary income was ¥2,651.504 million, up 27.5%, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥2,063.733 million, up 32.4%.」

    For the cumulative third quarter, the company disclosed year-on-year increases in revenue, operating income, ordinary income and net income attributable to owners of the parent.
  26. FY2020-Q2RestatedAnnual report

    「As a result, revenue was ¥4,152.522 million, up 9.3% year on year, and operating income was ¥1,153.835 million, up 10.7%. Ordinary income was ¥1,777.711 million, up 53.9%, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥1,378.682 million, up 64.8%.」

    For the cumulative second quarter, the company disclosed that revenue, operating income, ordinary income and net income attributable to owners of the parent exceeded the same period of the previous year.
  27. FY2020-Q1Disclosure of consolidated first-quarter results, including year-on-year comparisonsAnnual report

    「As a result, revenue was ¥2,073.390 million, up 7.7% year on year, and operating income was ¥585.761 million, up 9.5%. Ordinary income was ¥910.814 million, up 69.9%, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥709.325 million, up 90.3%.」

    Unlike the previous first quarter, for which no year-on-year comparison was made because it was the first year of consolidated financial reporting, the company disclosed year-on-year increases in revenue, operating income, ordinary income and net income attributable to owners of the parent.
  28. FY2019Disclosure of full-year consolidated resultsAnnual report

    「As a result, revenue was ¥7,792.295 million and operating income was ¥2,153.173 million. Ordinary income was ¥2,931.680 million, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥2,267.222 million.」

    The company disclosed revenue, operating income, ordinary income and net income attributable to owners of the parent as full-year results for the first year of preparing consolidated financial statements. No comparison with the previous consolidated fiscal year was made.
  29. FY2019-Q3RestatedAnnual report

    「As a result, revenue was ¥5,778.613 million and operating income was ¥1,586.953 million. Ordinary income was ¥2,079.568 million, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥1,558.815 million.」

    The company disclosed revenue, operating income, ordinary income and net income attributable to owners of the parent for the cumulative third quarter of the consolidated fiscal year. As this was the first year of consolidated financial reporting, no comparison with the same quarter of the previous year was made.
  30. FY2019-Q2RestatedAnnual report

    「As a result, revenue was ¥3,800.432 million and operating income was ¥1,042.620 million. Ordinary income was ¥1,155.355 million, reflecting the recognition of equity-method investment gains and other factors, while net income attributable to owners of the parent was ¥836.766 million.」

    For the cumulative second quarter of the first year of consolidated financial reporting, the company disclosed revenue, operating income, ordinary income and net income attributable to owners of the parent. Comparisons with the same period of the previous year and the previous consolidated fiscal year have not been made.
  31. FY2019-Q1Performance disclosure for the first year of consolidated reportingAnnual report

    「As a result, revenue totaled ¥1,924,581 thousand, operating profit totaled ¥535,016 thousand, ordinary profit totaled ¥536,192 thousand, and quarterly net profit attributable to owners of the parent totaled ¥372,764 thousand.」

    The disclosure reports first-quarter performance for the first year of consolidated reporting. Because the company had begun preparing quarterly consolidated financial statements, no comparative analysis with the same quarter of the previous year was conducted, and no comparison of revenue or profit growth was presented.
  32. FY2018RestatedAnnual report

    「As a result, revenue totaled ¥6,445,728 thousand, up 17.8% year on year, operating profit totaled ¥1,598,202 thousand, up 63.6%, ordinary profit totaled ¥1,622,799 thousand, up 66.4%, and net profit totaled ¥1,145,658 thousand, up 49.3%.」

    For the full year as well, revenue, operating profit, ordinary profit, and net profit exceeded the same period of the previous year.
  33. FY2018-Q3RestatedAnnual report

    「As a result, revenue totaled ¥4,640,888 thousand, up 12.8% year on year, operating profit totaled ¥1,174,037 thousand, up 77.6%, ordinary profit totaled ¥1,193,191 thousand, up 90.1%, and quarterly net profit totaled ¥828,652 thousand, up 61.5%.」

    The disclosure states that revenue, operating profit, ordinary profit, and quarterly net profit for the nine months ended the third quarter also exceeded the same period of the previous year.
  34. FY2018-Q2RestatedAnnual report

    「As a result, revenue totaled ¥2,955,142 thousand, up 5.9% year on year, operating profit totaled ¥757,737 thousand, up 52.8%, ordinary profit totaled ¥766,653 thousand, up 66.1%, and quarterly net profit totaled ¥533,395 thousand, up 31.6%.」

    The disclosure states that revenue, operating profit, ordinary profit, and quarterly net profit for the six months ended the second quarter also exceeded the same period of the previous year.
  35. FY2018-Q1RestatedAnnual report

    「As a result, revenue totaled ¥1,422,932 thousand, up 1.0% year on year, operating profit totaled ¥360,096 thousand, up 41.4%, ordinary profit totaled ¥365,226 thousand, up 56.7%, and quarterly net profit totaled ¥256,515 thousand, up 1.7%.」

    The disclosure states that first-quarter revenue, operating profit, ordinary profit, and quarterly net profit exceeded the same period of the previous year.
  36. FY2017RestatedAnnual report

    「As a result, revenue totaled ¥5,469,985 thousand, up 10.4% year on year, operating profit totaled ¥976,987 thousand, up 35.4%, and ordinary profit totaled ¥975,492 thousand, up 40.7%.」

    The disclosure states that full-year revenue, operating profit, ordinary profit, and net profit exceeded the same period of the previous year.
  37. FY2017-Q3RestatedAnnual report

    「As a result, revenue totaled ¥4,115,046 thousand, up 10.3% year on year, operating profit totaled ¥661,174 thousand, up 13.7%, ordinary profit totaled ¥627,784 thousand, up 10.1%, and quarterly net profit totaled ¥512,945 thousand, up 43.1%. In addition, pretax quarterly net profit totaled ¥770,643 thousand, up 35.1%, due to the recognition of a gain on the sale of investment securities as extraordinary income.」

    Revenue, operating profit, ordinary profit, and quarterly net profit for the nine months ended the third quarter also exceeded the same period of the previous year. Pretax quarterly net profit and quarterly net profit included the impact of a gain on the sale of investment securities.
  38. FY2017-Q2RestatedAnnual report

    「As a result, revenue totaled ¥2,789,446 thousand, up 10.9% year on year, operating profit totaled ¥495,961 thousand, up 23.6%, ordinary profit totaled ¥461,468 thousand, up 10.8%, and quarterly net profit totaled ¥405,305 thousand, up 52.3%. In addition, pretax quarterly net profit totaled ¥604,326 thousand, up 45.1%, due to the recognition of a gain on the sale of investment securities as extraordinary income.」

    Revenue, operating profit, ordinary profit, and quarterly net profit for the six months ended the second quarter also exceeded the same period of the previous year. Pretax quarterly net profit and net profit included the impact of a gain on the sale of investment securities.
  39. FY2017-Q1First statedAnnual report

    「As a result, revenue was ¥1,408,782 thousand, up 15.7% year on year, operating profit was ¥254,711 thousand, up 25.5%, and ordinary profit was ¥233,025 thousand, up 8.4%. In addition, pretax profit for the quarter was ¥375,884 thousand, up 74.9%, due to the recognition of a gain on the sale of investment securities as extraordinary income, while net profit for the quarter was ¥252,297 thousand, up 83.2%.」

    The disclosure reports year-on-year increases in revenue, operating profit, ordinary profit and net profit for the quarter. It also notes that the increases in pretax profit for the quarter and net profit included a gain on the sale of investment securities recognized as extraordinary income.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tri Chemical Laboratories yet. It last moved in the Revisions to earnings forecasts of 2026-08-31: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Quarterly Revenue and Profit Growth | Tri Chemical Laboratories Inc. (4369) | Komori